BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 34740601)

  • 1. Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study.
    Sun L; Zhu Z; Shi M; Jia Y; Yang P; Wang Y; Liu F; Zhang Y
    Clin Chim Acta; 2021 Dec; 523():491-496. PubMed ID: 34740601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis, coronary artery disease, and myocardial infarction: A mendelian randomization study.
    Xu H; Ling Y; Jiang H; Li Y; Jiang M
    Front Cardiovasc Med; 2022; 9():892742. PubMed ID: 36093168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal effect of lipoprotein-associated phospholipase A2 activity on ischemic stroke : a Mendelian randomization study.
    Zhang Y; Jiang M; Gao Y; Xu Y; Zhou Y; Wu D; Zhou C; Liu G; Li M; Ji X
    Cerebrovasc Dis; 2023 Dec; ():. PubMed ID: 38113871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Vitamin E Levels and Risk of Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study.
    Wang T; Xu L
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31505768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of visceral adipose tissue mass on coronary artery disease and heart failure: A Mendelian randomization study.
    Chen Q; Wu Y; Gao Y; Zhang Z; Shi T; Yan B
    Int J Obes (Lond); 2022 Dec; 46(12):2102-2106. PubMed ID: 35995978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction.
    Larsson SC; Burgess S; Michaëlsson K
    JAMA; 2017 Jul; 318(4):371-380. PubMed ID: 28742912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Intelligence Predicts Higher Risks of Coronary Artery Disease and Myocardial Infarction: Evidence From Mendelian Randomization Study.
    Yang F; Hu T; Chen S; Wang K; Qu Z; Cui H
    Front Genet; 2022; 13():756901. PubMed ID: 35198002
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction.
    Zhang MM; Zhang CG; Yang CJ; Zhao P; Li YL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3960-3966. PubMed ID: 31115024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent Causal Effect of Remnant Cholesterol on Atherosclerotic Cardiovascular Outcomes: A Mendelian Randomization Study.
    Navarese EP; Vine D; Proctor S; Grzelakowska K; Berti S; Kubica J; Raggi P
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):e373-e380. PubMed ID: 37439258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study.
    Miao L; Deng GX; Yin RX; Nie RJ; Yang S; Wang Y; Li H
    Eur J Prev Cardiol; 2021 Apr; 28(2):227–234. PubMed ID: 33838042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
    Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
    Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
    Grallert H; Dupuis J; Bis JC; Dehghan A; Barbalic M; Baumert J; Lu C; Smith NL; Uitterlinden AG; Roberts R; Khuseyinova N; Schnabel RB; Rice KM; Rivadeneira F; Hoogeveen RC; Fontes JD; Meisinger C; Keaney JF; Lemaitre R; Aulchenko YS; Vasan RS; Ellis S; Hazen SL; van Duijn CM; Nelson JJ; März W; Schunkert H; McPherson RM; Stirnadel-Farrant HA; Psaty BM; Gieger C; Siscovick D; Hofman A; Illig T; Cushman M; Yamamoto JF; Rotter JI; Larson MG; Stewart AF; Boerwinkle E; Witteman JC; Tracy RP; Koenig W; Benjamin EJ; Ballantyne CM
    Eur Heart J; 2012 Jan; 33(2):238-51. PubMed ID: 22003152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.
    Pan Y; Li H; Wang Y; Meng X; Wang Y
    Stroke; 2019 Dec; 50(12):3532-3539. PubMed ID: 31597550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the gut microbiota with coronary artery disease and myocardial infarction: A Mendelian randomization study.
    Wang D; Chen X; Li Z; Luo Y
    Front Genet; 2023; 14():1158293. PubMed ID: 37113988
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.
    Yang F; Lu Y; Chen S; Wang K; Hu T; Cui H
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1266-1274. PubMed ID: 35197211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.